v3.25.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Revenue:        
Collaboration agreements $ 250 $ 1,073 $ 250 $ 53,477
Operating expenses:        
Research and development, net of tax credits 14,283 30,075 34,553 63,045
General and administrative 6,029 8,317 13,681 16,935
Restructuring 3,384 0 6,649 0
Total operating expenses 23,696 38,392 54,883 79,980
Gain on sale of technology and other assets 5,666 0 5,666 0
Loss from operations (17,780) (37,319) (48,967) (26,503)
Other income (expense), net        
Realized and unrealized gain on foreign exchange 66 6 64 37
Interest income 1,236 2,894 2,774 5,862
Other expense, net (18) (29) (40) (53)
Total other income, net 1,284 2,871 2,798 5,846
Loss before income taxes (16,496) (34,448) (46,169) (20,657)
Income tax expense (248) (326) (618) (955)
Net loss (16,744) (34,774) (46,787) (21,612)
Other comprehensive loss:        
Unrealized loss on available-for-sale marketable securities (17) (21) (62) (162)
Total other comprehensive loss (17) (21) (62) (162)
Comprehensive loss $ (16,761) $ (34,795) $ (46,849) $ (21,774)
Net loss per share attributable to common shareholders - basic $ (0.39) $ (0.82) $ (1.09) $ (0.51)
Net loss per share attributable to common shareholders - diluted $ (0.39) $ (0.82) $ (1.09) $ (0.51)
Weighted-average common shares outstanding - basic 42,921,936 42,445,462 42,757,745 42,339,732
Weighted-average common shares outstanding - diluted 42,921,936 42,445,462 42,757,745 42,339,732